Tomasz Liberek

1.3k total citations
49 papers, 892 citations indexed

About

Tomasz Liberek is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomasz Liberek has authored 49 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Nephrology, 16 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomasz Liberek's work include Dialysis and Renal Disease Management (18 papers), Central Venous Catheters and Hemodialysis (9 papers) and Renal Diseases and Glomerulopathies (6 papers). Tomasz Liberek is often cited by papers focused on Dialysis and Renal Disease Management (18 papers), Central Venous Catheters and Hemodialysis (9 papers) and Renal Diseases and Glomerulopathies (6 papers). Tomasz Liberek collaborates with scholars based in Poland, United Kingdom and Germany. Tomasz Liberek's co-authors include Nicholas Topley, Achim Jörres, Gerald A. Coles, Gerhard M. Gahl, J D Williams, Janusz Witowski, Meryl M. Petersen, Monika Lichodziejewska–Niemierko, Gerald A. Coles and Werner Luttmann and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Physiology-Renal Physiology.

In The Last Decade

Tomasz Liberek

42 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Liberek Poland 14 591 293 161 157 109 49 892
M. W. J. A. Fieren Netherlands 17 536 0.9× 330 1.1× 179 1.1× 84 0.5× 63 0.6× 31 891
Thorsten O. Bender Germany 15 538 0.9× 275 0.9× 107 0.7× 90 0.6× 34 0.3× 28 736
Antonio Cirugeda Spain 18 528 0.9× 306 1.0× 161 1.0× 174 1.1× 70 0.6× 29 775
Ruth Mackenzie United Kingdom 12 1.2k 2.0× 716 2.4× 288 1.8× 268 1.7× 59 0.5× 16 1.6k
Leïla Chénine France 13 475 0.8× 166 0.6× 73 0.5× 129 0.8× 91 0.8× 32 667
Hiroaki Io Japan 15 446 0.8× 226 0.8× 100 0.6× 82 0.5× 60 0.6× 66 700
Krzysztof Pawlaczyk Poland 15 333 0.6× 168 0.6× 106 0.7× 43 0.3× 203 1.9× 64 913
Izumi Amano Japan 13 272 0.5× 161 0.5× 275 1.7× 298 1.9× 51 0.5× 29 725
F.M.J. Zuyderhoudt Netherlands 15 331 0.6× 152 0.5× 94 0.6× 113 0.7× 67 0.6× 30 709
V. de Précigout France 16 422 0.7× 110 0.4× 108 0.7× 49 0.3× 206 1.9× 44 671

Countries citing papers authored by Tomasz Liberek

Since Specialization
Citations

This map shows the geographic impact of Tomasz Liberek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Liberek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Liberek more than expected).

Fields of papers citing papers by Tomasz Liberek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Liberek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Liberek. The network helps show where Tomasz Liberek may publish in the future.

Co-authorship network of co-authors of Tomasz Liberek

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Liberek. A scholar is included among the top collaborators of Tomasz Liberek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Liberek. Tomasz Liberek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nowicki, Michał, Stanisława Bazan‐Socha, Mariusz Kłopotowski, et al.. (2024). Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease. Orphanet Journal of Rare Diseases. 19(1). 139–139.
2.
Nowicki, Michał, Stanisława Bazan‐Socha, Mariusz Kłopotowski, et al.. (2024). A review and recommendations for oral chaperone therapy in adult patients with Fabry disease. Orphanet Journal of Rare Diseases. 19(1). 16–16. 6 indexed citations
3.
Heleniak, Zbigniew, et al.. (2023). COVID-19 and vasculitis case report and review of the literature. 16(3). 108–111.
4.
Sikorska, Katarzyna, et al.. (2021). Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (−) Negative in the Serum. Case Reports in Nephrology and Dialysis. 11(2). 110–115. 3 indexed citations
5.
Heleniak, Zbigniew, et al.. (2019). Life threatening bleeding from arcuate kidney artery aneurysm as a rare complication of granulomatosis with polyangiitis. Polskie Archiwum Medycyny Wewnętrznej. 129(12). 930–931. 2 indexed citations
6.
Liberek, Tomasz, et al.. (2016). Survival of tunneled hemodialysis catheters after percutaneous placement.. Acta Biochimica Polonica. 63(1). 139–143. 6 indexed citations
7.
Perkowska‐Ptasińska, Agnieszka, Dominika Dęborska−Materkowska, Tomasz Stompór, et al.. (2016). Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrology. 17(1). 194–194. 28 indexed citations
8.
Wołyniec, Wojciech, et al.. (2015). Cewniki tunelizowane w dializoterapii — dobrodziejstwo czy zło konieczne?. Via Medica Journals. 8(4). 205–213. 1 indexed citations
9.
Liberek, Tomasz, et al.. (2013). Biopharmaceutics in nephrology. 6(3). 139–149. 1 indexed citations
10.
Liberek, Tomasz, et al.. (2013). Leki biologiczne w nefrologii. Via Medica Journals. 6(3). 139–149. 1 indexed citations
11.
Liberek, Tomasz, et al.. (2013). Prolonged renal failure in the course of atypical ethylene glycol intoxication.. Acta Biochimica Polonica. 60(4). 661–3. 2 indexed citations
12.
Bułło‐Piontecka, Barbara, Tomasz Liberek, & Leszek Rutkowski. (2012). Mykofenolan mofetilu w leczeniu nefropatii toczniowej. 5(4). 351–360.
13.
Liberek, Anna, Zbigniew Kmieć, Piotr Wierzbicki, et al.. (2012). The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children. International Journal of Colorectal Disease. 28(2). 165–172. 3 indexed citations
14.
Liberek, Tomasz. (2010). Pacjent z cukrzycową chorobą nerek. Via Medica Journals.
15.
Małgorzewicz, Sylwia, et al.. (2010). Oxidative stress, inflammation and nutritional status during darbepoetin α treatment in peritoneal dialysis patients. Clinical Nephrology. 73(3). 210–215. 5 indexed citations
16.
Liberek, Tomasz, Marcin Renke, Jolanta Kowalewska, et al.. (2009). Therapy outcome in peritoneal dialysis patients transferred from haemodialysis. Nephrology Dialysis Transplantation. 24(9). 2889–2894. 33 indexed citations
17.
Piotrowska, Ewa, Joanna Jakóbkiewicz‐Banecka, Anna Tylki‐Szymańska, et al.. (2008). Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients. Current Therapeutic Research. 69(2). 166–179. 85 indexed citations
18.
Liberek, Tomasz, Marcin Renke, Monika Lichodziejewska–Niemierko, & Piotr Rutkowski. (1999). The Role of Automated Peritoneal Dialysis in Peritoneal Dialysis Programme: One Centre Experience. The International Journal of Artificial Organs. 22(11). 734–738. 3 indexed citations
19.
Witowski, Janusz, et al.. (1995). Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney International. 47(1). 282–293. 92 indexed citations
20.
Liberek, Tomasz, Nicholas Topley, Achim Jörres, et al.. (1993). Peritoneal Dialysis Fluid Inhibition of Polymorphonuclear Leukocyte Respiratory Burst Activation Is Related to the Lowering of Intracellular pH. ˜The œNephron journals/Nephron journals. 65(2). 260–265. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. W. J. A. Fieren Breakdown of academic impact, for papers by Thorsten O. Bender Breakdown of academic impact, for papers by Antonio Cirugeda Breakdown of academic impact, for papers by Ruth Mackenzie Breakdown of academic impact, for papers by Leïla Chénine Breakdown of academic impact, for papers by Hiroaki Io Breakdown of academic impact, for papers by Krzysztof Pawlaczyk Breakdown of academic impact, for papers by Izumi Amano Breakdown of academic impact, for papers by F.M.J. Zuyderhoudt Breakdown of academic impact, for papers by V. de Précigout
Rankless by CCL
2026